Ligand binding and conformational changes of SUR1 subunit in pancreatic ATP-sensitive potassium channels

Abstract

ATP-sensitive potassium channels (K_ATP) are energy sensors on the plasma membrane. By sensing the intracellular ADP/ATP ratio of β-cells, pancreatic K_ATP channels control insulin release and regulate metabolism at the whole body level. They are implicated in many metabolic disorders and diseases and are therefore important drug targets. Here, we present three structures of pancreatic K_ATP channels solved by cryoelectron microscopy (cryo-EM), at resolutions ranging from 4.1 to 4.5 Å. These structures depict the binding site of the antidiabetic drug glibenclamide, indicate how Kir6.2 (inward-rectifying potassium channel 6.2) N-terminus participates in the coupling between the peripheral SUR1 (sulfonylurea receptor 1) subunit and the central Kir6.2 channel, reveal the binding mode of activating nucleotides, and suggest the mechanism of how Mg-ADP binding on nucleotide binding domains (NBDs) drives a conformational change of the SUR1 subunit.

Keywords

K_ATP / SUR / ABC transporter / glibenclamide / sulfonylurea / diabetes

References

[1] Adams PD (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213–221

[2] Aguilar-Bryan L (1990) Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog. J Biol Chem 265:8218–8224

[3] Aguilar-Bryan L (1995) Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268:423–426

[4] Aittoniemi J (2009) Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator. Philos Trans R Soc Lond B Biol Sci 364:257–267

[5] Ashcroft FM (2017) Neonatal diabetes and the KATP channel: from mutation to therapy. Trends Endocrinol Metab 28:377–387

[6] Babenko AP, Bryan J (2002) SUR-dependent modulation of KATP channels by an N-terminal KIR6.2 peptide. Defining intersubunit gating interactions. J Biol Chem 277:43997–44004

[7] Babenko AP (1999) The N-terminus of KIR6.2 limits spontaneous bursting and modulates the ATP-inhibition of KATP channels. Biochem Biophys Res Commun 255:231–238

[8] Bai XC (2015) Sampling the conformational space of the catalytic subunit of human gamma-secretase. Elife. https://doi.org/10.7554/eLife.11182

[9] Baukrowitz T (1998) PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science 282:1141–1144

[10] Bryan J (2005) Insulin secretagogues, sulfonylurea receptors and K(ATP) channels. Curr Pharm Des 11:2699–2716

[11] Carr RD (2003) NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat. Diabetes 52:2513–2518

[12] Chen S (2013) High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135:24–35

[13] Choi KH (2008) Testing for violations of microscopic reversibility in ATP-sensitive potassium channel gating. J Phys Chem B 112:10314–10321

[14] Clement JPT (1997) Association and stoichiometry of K(ATP) channel subunits. Neuron 18:827–838

[15] Devaraneni PK (2015) Structurally distinct ligands rescue biogenesis defects of the KATP channel complex via a converging mechanism. J Biol Chem 290:7980–7991

[16] Emsley P (2010) Features and development of coot. Acta Crystallogr D Biol Crystallogr 66:486–501

[17] Flagg TP (2010) Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev 90:799–829

[18] Goehring A (2014) Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat Protoc 9:2574–2585

[19] Gribble FM (1997) The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K⁺channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol 504 (Pt 1):35–45

[20] Hibino H (2010) Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90:291–366

[21] Hilgemann DW, Ball R (1996) Regulation of cardiac Na⁺, Ca²⁺exchange and KATP potassium channels by PIP2. Science 273:956–959

[22] Hopkins WF (1992) Two sites for adenine-nucleotide regulation of ATP-sensitive potassium channels in mouse pancreatic betacells and HIT cells. J Membr Biol 129:287–295

[23] Jones PM, George AM (2017) How intrinsic dynamics mediates the allosteric mechanism in the ABC transporter nucleotide binding domain dimer. J Chem Theory Comput 13:1712–1722

[24] Karpowich N (2001) Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. Structure 9:571–586

[25] Kawate T, Gouaux E (2006) Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. Structure 14:673–681

[26] Kimanius D (2016) Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. Elife. https://doi.org/10.7554/eLife.18722

[27] Koster JC (1999) ATP inhibition of KATP channels: control of nucleotide sensitivity by the N-terminal domain of the Kir6.2 subunit. J Physiol 515(Pt 1):19–30

[28] Kuhner P (2012) Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic K (ATP) channel. Naunyn Schmiedebergs Arch Pharmacol 385:299–311

[29] Lee KPK (2017) Molecular structure of human KATP in complex with ATP and ADP. Elife. https://doi.org/10.7554/eLife.32481

[30] Li N (2017) Structure of a pancreatic ATP-sensitive potassium channel. Cell 168:101–110

[31] Locher KP (2016) Mechanistic diversity in ATP-binding cassette (ABC) transporters. Nat Struct Mol Biol 23:487–493

[32] Martin GM (2017a) Anti-diabetic drug binding site in a mammalian KATP channel revealed by Cryo-EM. Elife. https://doi.org/10.7554/eLife.31054

[33] Martin GM (2017b) Cryo-EM structure of the ATP-sensitive potassium channel illuminates mechanisms of assembly and gating. Elife. https://doi.org/10.7554/eLife.24149

[34] Matsuo M (1999a) ATP binding properties of the nucleotidebinding folds of SUR1. J Biol Chem 274:37479–37482

[35] Matsuo M (1999b) NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1. FEBS Lett 458:292–294

[36] Nichols CG (1996) Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272:1785–1787

[37] Ortiz D (2013) Reinterpreting the action of ATP analogs on K (ATP) channels. J Biol Chem 288:18894–18902

[38] Pettersen EF (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612

[39] Proks P (1999) Involvement of the N-terminus of Kir6.2 in the inhibition of the KATP channel by ATP. J Physiol 514(Pt 1):19–25

[40] Proks P (2010) Activation of the K(ATP) channel by Mgnucleotide interaction with SUR1. J Gen Physiol 136:389–405

[41] Punjani A (2017) cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods 14:290–296

[42] Reimann F (1999) Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor. J Physiol 518(Pt 2):325–336

[43] Schwanstecher C (1994a) Interaction of tolbutamide and cytosolic nucleotides in controlling the ATP-sensitive K+ channel in mouse beta-cells. Br J Pharmacol 111:302–310

[44] Schwanstecher M (1994b) Identification of a 38-kDa high affinity sulfonylurea-binding peptide in insulin-secreting cells and cerebral cortex. J Biol Chem 269:17768–17771

[45] Shimomura K (2006) Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects. Diabetes 55:1705–1712

[46] Shyng S, Nichols CG (1997) Octameric stoichiometry of the KATP channel complex. J Gen Physiol 110:655–664

[47] Shyng SL, Nichols CG (1998) Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science 282:1138–1141

[48] Shyng S (1997) Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor. J Gen Physiol 110:643–654

[49] Suloway C (2005) Automated molecular microscopy: the new Leginon system. J Struct Biol 151:41–60

[50] Ueda K (1997) MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1. J Biol Chem 272:22983–22986

[51] Ueda K (1999) Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide. Proc Natl Acad Sci USA 96:1268–1272

[52] Vedovato N (2015) The nucleotide-binding sites of SUR1: a mechanistic model. Biophys J 109:2452–2460

[53] Vila-Carriles WH (2007) Defining a binding pocket for sulfonylureas in ATP-sensitive potassium channels. FASEB J 21:18–25

[54] Whorton MR, MacKinnon R (2011) Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium. Cell 147:199–208

[55] Whorton MR, MacKinnon R (2013) X-ray structure of the mammalian GIRK2-betagamma G-protein complex. Nature 498:190–197

[56] Woo SK (2013) The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J Biol Chem 288:3655–3667

[57] Zhang K (2016) Gctf: real-time CTF determination and correction. J Struct Biol 193:1–12

[58] Zhang Z, Chen J (2016) Atomic structure of the cystic fibrosis transmembrane conductance regulator. Cell 167(1586–1597):e1589

[59] Zhang Z (2017) Conformational changes of CFTR upon phosphorylation and ATP binding. Cell 170(483–491):e488

[60] Zhao Y (2015) In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis. Chem Biol Interact 240:310–315

[61] Zheng SQ (2017) MotionCor2: anisotropic correction of beaminduced motion for improved cryo-electron microscopy. Nat Methods 14:331–332

[62] Zhou M (2015) Atomic structure of the apoptosome: mechanism of cytochrome c- and dATP-mediated activation of Apaf-1. Genes Dev 29:2349–2361

RIGHTS & PERMISSIONS

2018 The Author(s) 2018